APRIL 2014 ISSUE:

Novartis AG and Another v Ranbaxy (Malaysia) Sdn. Bhd.

In the case of Novartis AG and Another v Ranbaxy (Malaysia) Sdn. Bhd. [2013] 2 SLR 117, the plaintiff was the proprietor of a Singapore patent and the defendant sought to import a pharmaceutical product which related to the plaintiff’s patent. Under the Singapore Medicines Act, the defendant’s had a duty to inform the Plaintiff of their applications for ... more

Exceptions to Loss of Novelty for Malaysian Patents

Malaysian patent law has a worldwide novelty standard, qualified by a 12-month grace period. Section 14(3) of the Malaysian Patents Act stipulates that this grace period is available to a patent applicant in respect of disclosures that are by reason or in consequence ... more

Code of Good Conduct For Malaysian IP Agents

Effective 01 January 2014, the Malaysian Intellectual Property Office (“MyIPO”) has released a set of guidelines for the good conduct of IP Agents. Its main purpose and objective is to introduce and put in place a set of rules to be adhered by all IP practitioners in Malaysia as to what constitutes good conduct and acceptable practices. Some of these guidelines ... more

Top 10 PCT filers in 2013

According to WIPO, there were about 205,300 PCT applications filed in 2013. This represents an increase of 5.1% over 2012. The top 10 filing countries are USA, Japan, China, Germany, Republic of Korea, France, UK, Switzerland, ... more

Terms and Conditions | Privacy Policy | DisclaimerCopyright © 2009 - 2019  Henry Goh (S) Pte Ltd